Amplification of the genes for both components of ribonucleotide reductase in hydroxyurea resistant mammalian cells.
Ribonucleotide reductase catalyzes the formation of deoxyribonucleotides from ribonucleoside diphosphate precursors, and is a rate-limiting step in the synthesis of DNA. The enzyme consists of two dissimilar subunits usually called M1 and M2. The antitumor agent, hydroxyurea, is a specific inhibitor of DNA synthesis and acts by destroying the tyrosyl free radical of the M2 subunit of ribonucleotide reductase. Two highly drug resistant cell lines designated HR-15 and HR-30 were isolated by exposing a population of mouse L cells to increasing concentrations of hydroxyurea. HR-15 and HR-30 cells contained elevated levels of ribonucleotide reductase activity, and were 68 and 103 times, respectively, more resistant than wild type to the cytotoxic effects of hydroxyurea. Northern and Southern blot analysis indicated that the two drug resistant lines contained elevated levels of M2 mRNA and M2 gene copy numbers. Similar studies with M1 specific cDNA demonstrated that HR-15 and HR-30 cell lines also contained increased M1 message levels, and showed M1 gene amplification. Mutant cell lines altered in expression and copy numbers for both the M1 and M2 genes are useful for obtaining information relevant to the regulation of ribonucleotide reductase, and its role in DNA synthesis and cell proliferation.
Hurta
R A
RA
Department of Biochemistry, University of Manitoba, Winnipeg, Canada.
Wright
J A
JA
D000818:Animals; D015152:Blotting, Northern; D015139:Blotting, Southern; D002478:Cells, Cultured; D003114:Colony-Forming Units Assay; D004247:DNA / Q000235:genetics; D004351:Drug Resistance; D005784:Gene Amplification; D006918:Hydroxyurea / Q000494:pharmacology*; D008322:Mammals; D012333:RNA, Messenger / Q000235:genetics; D012264:Ribonucleotide Reductases / Q000235:genetics*
D012333:RNA, Messenger; D004247:DNA; D012264:Ribonucleotide Reductases; D006918:Hydroxyurea